Share Price and Basic Stock Data
Last Updated: January 22, 2026, 1:39 pm
| PEG Ratio | -0.62 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Indo Rama Synthetics (India) Ltd operates in the textiles sector, specifically focusing on synthetic blended spinning. The company’s market capitalization stood at ₹1,011 Cr, with its share price at ₹39.0. The revenue from operations for the trailing twelve months (TTM) reached ₹4,890 Cr, reflecting a notable increase from ₹4,085 Cr reported in March 2023. Quarterly sales exhibited volatility, with a peak of ₹1,259 Cr in September 2023, followed by a decline to ₹770 Cr in June 2023. However, sales rebounded to ₹1,166 Cr in December 2024, indicating recovery trends. The operating profit margin (OPM) remained low at 6%, suggesting that the company faces challenges in controlling costs relative to its sales. Overall, Indo Rama’s revenue trends indicate a recovery post-pandemic, but the volatility in quarterly sales highlights potential demand fluctuations in the textiles market.
Profitability and Efficiency Metrics
Indo Rama’s profitability metrics reveal a challenging landscape, with a reported net profit of ₹142 Cr, leading to a price-to-earnings (P/E) ratio of 7.12. The operating profit for the fiscal year ending March 2025 was ₹179 Cr, a significant improvement from the previous year when it recorded an operating loss of ₹37 Cr. The company’s return on equity (ROE) stood at 0.66%, while return on capital employed (ROCE) was higher at 9.94%. The interest coverage ratio (ICR) was reported at 1.32x, indicating that Indo Rama’s earnings are just sufficient to cover its interest obligations. The cash conversion cycle (CCC) of -63 days highlights efficient management of working capital, as the company converts its investments in inventory into cash quickly. However, the low OPM and ROE raise concerns about its overall profitability and efficiency compared to industry averages.
Balance Sheet Strength and Financial Ratios
Indo Rama’s balance sheet reflects significant borrowings of ₹1,087 Cr against reserves of ₹184 Cr, resulting in a total debt-to-equity ratio of 3.06x, indicating a high leverage situation. The company’s fixed assets were valued at ₹1,264 Cr, which, combined with total liabilities of ₹2,936 Cr, raises questions about asset management. The current ratio stood at 0.62, suggesting liquidity concerns as it falls below the ideal benchmark of 1.0. Despite these challenges, the company reported a book value per share of ₹14.10, indicating a tangible net worth. Financial ratios such as the inventory turnover ratio of 7.19x demonstrate operational efficiency, particularly in managing inventory. While the asset turnover ratio is at 1.46, indicating effective use of assets, the high leverage ratio could pose risks in adverse market conditions.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Indo Rama Synthetics indicates strong promoter confidence, with promoters holding 74.84% of the equity. This stability is complemented by public shareholding at 23.86%, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold minor stakes of 0.37% and 0.92%, respectively. The total number of shareholders decreased to 26,651 in September 2025 from a peak of 30,271 in December 2024, reflecting potential investor wariness. The decline in institutional ownership, particularly from FIIs, suggests a cautious outlook among institutional investors regarding the company’s performance. The consistent promoter holding may provide a stabilizing factor, but the slight drop in public shareholding and investor sentiment warrants attention for future capital raising and strategic initiatives.
Outlook, Risks, and Final Insight
Indo Rama Synthetics faces a mixed outlook driven by its recovery in sales and profitability metrics, but significant risks remain. The company’s high leverage poses financial risks, especially in a volatile economic environment. Additionally, the low OPM and ROE compared to sector norms indicate challenges in sustaining profitability. On the upside, the efficient cash conversion cycle and robust promoter support may enhance operational stability. The company’s future performance will hinge on its ability to manage costs effectively while navigating market fluctuations. If Indo Rama can leverage its strengths in operational efficiency and maintain robust sales growth, it may improve its financial health. However, the persistent high debt levels and competitive pressures in the textiles industry could impact its long-term viability. Stakeholders should closely monitor these dynamics to make informed investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Threads (I) Ltd | 137 Cr. | 39.5 | 62.0/31.4 | 25.0 | 0.00 % | 2.90 % | 1.41 % | 10.0 | |
| Deepak Spinners Ltd | 72.8 Cr. | 101 | 189/100.0 | 311 | 0.00 % | 3.67 % | 4.31 % | 10.0 | |
| APM Industries Ltd | 78.0 Cr. | 36.1 | 50.0/31.0 | 98.8 | 78.6 | 0.00 % | 1.02 % | 0.32 % | 2.00 |
| Aditya Spinners Ltd | 28.5 Cr. | 17.0 | 27.4/15.4 | 27.3 | 0.00 % | 1.17 % | 3.82 % | 10.0 | |
| Adinath Textiles Ltd | 12.5 Cr. | 18.4 | 43.4/15.5 | 4.39 | 0.00 % | 3.75 % | 2.73 % | 10.0 | |
| Industry Average | 861.20 Cr | 94.20 | 38.21 | 130.19 | 0.14% | 4.20% | 2.96% | 8.20 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,137 | 890 | 880 | 770 | 1,259 | 940 | 904 | 944 | 951 | 1,166 | 1,198 | 1,306 | 1,221 |
| Expenses | 1,135 | 932 | 857 | 794 | 1,228 | 997 | 895 | 915 | 948 | 1,102 | 1,116 | 1,215 | 1,152 |
| Operating Profit | 2 | -42 | 23 | -24 | 31 | -56 | 10 | 29 | 3 | 63 | 82 | 91 | 68 |
| OPM % | 0% | -5% | 3% | -3% | 2% | -6% | 1% | 3% | 0% | 5% | 7% | 7% | 6% |
| Other Income | 19 | 0 | 5 | 1 | 1 | 4 | 1 | 1 | 3 | 2 | 23 | 3 | 2 |
| Interest | 12 | 16 | 20 | 24 | 31 | 37 | 41 | 38 | 38 | 40 | 42 | 29 | 34 |
| Depreciation | 8 | 8 | 8 | 8 | 10 | 10 | 11 | 12 | 12 | 13 | 12 | 12 | 12 |
| Profit before tax | 1 | -66 | 0 | -55 | -9 | -99 | -40 | -19 | -44 | 14 | 51 | 53 | 25 |
| Tax % | -16% | 0% | -1,373% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 1 | -66 | 2 | -55 | -9 | -99 | -40 | -19 | -44 | 14 | 51 | 53 | 25 |
| EPS in Rs | 0.04 | -2.52 | 0.06 | -2.11 | -0.34 | -3.79 | -1.55 | -0.73 | -1.69 | 0.52 | 1.96 | 2.02 | 0.94 |
Last Updated: January 1, 2026, 7:46 am
Below is a detailed analysis of the quarterly data for Indo Rama Synthetics (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,221.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,306.00 Cr. (Jun 2025) to 1,221.00 Cr., marking a decrease of 85.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,152.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,215.00 Cr. (Jun 2025) to 1,152.00 Cr., marking a decrease of 63.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Jun 2025) to 68.00 Cr., marking a decrease of 23.00 Cr..
- For OPM %, as of Sep 2025, the value is 6.00%. The value appears to be declining and may need further review. It has decreased from 7.00% (Jun 2025) to 6.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Jun 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Jun 2025) to 34.00 Cr., marking an increase of 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 12.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Jun 2025) to 25.00 Cr., marking a decrease of 28.00 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Jun 2025) to 25.00 Cr., marking a decrease of 28.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.94. The value appears to be declining and may need further review. It has decreased from 2.02 (Jun 2025) to 0.94, marking a decrease of 1.08.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:12 am
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,908 | 2,656 | 2,758 | 2,525 | 2,459 | 2,106 | 2,043 | 4,038 | 4,085 | 3,873 | 4,259 | 4,890 |
| Expenses | 2,867 | 2,629 | 2,635 | 2,464 | 2,479 | 2,128 | 1,950 | 3,734 | 4,041 | 3,910 | 4,080 | 4,586 |
| Operating Profit | 41 | 27 | 122 | 61 | -20 | -22 | 93 | 304 | 44 | -37 | 179 | 305 |
| OPM % | 1% | 1% | 4% | 2% | -1% | -1% | 5% | 8% | 1% | -1% | 4% | 6% |
| Other Income | 202 | 136 | 5 | -24 | 55 | 20 | 10 | 9 | 22 | 4 | 28 | 30 |
| Interest | 45 | 50 | 43 | 54 | 91 | 92 | 66 | 62 | 60 | 132 | 157 | 144 |
| Depreciation | 158 | 143 | 117 | 78 | 79 | 86 | 34 | 31 | 31 | 39 | 48 | 49 |
| Profit before tax | 40 | -31 | -33 | -94 | -135 | -180 | 3 | 219 | -25 | -203 | 1 | 142 |
| Tax % | -1% | -56% | -38% | -140% | -40% | 75% | -3,245% | -23% | -1% | 0% | 0% | |
| Net Profit | 40 | -14 | -21 | 38 | -81 | -317 | 113 | 269 | -25 | -203 | 1 | 142 |
| EPS in Rs | 2.65 | -0.89 | -1.36 | 2.48 | -5.36 | -12.12 | 4.34 | 10.30 | -0.94 | -7.79 | 0.05 | 5.44 |
| Dividend Payout % | 38% | -112% | -73% | 40% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -135.00% | -50.00% | 280.95% | -313.16% | 135.65% | 138.05% | -109.29% | -712.00% | 100.49% |
| Change in YoY Net Profit Growth (%) | 0.00% | 85.00% | 330.95% | -594.11% | 448.80% | 2.41% | -247.35% | -602.71% | 812.49% |
Indo Rama Synthetics (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2013-2014 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 15% |
| 3 Years: | 2% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 15% |
| 3 Years: | -79% |
| TTM: | 144% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 23% |
| 3 Years: | -5% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | -15% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 7:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:25 am
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 152 | 152 | 152 | 152 | 152 | 261 | 261 | 261 | 261 | 261 | 261 | 261 |
| Reserves | 476 | 436 | 397 | 450 | 350 | -39 | 72 | 339 | 312 | 107 | 107 | 184 |
| Borrowings | 713 | 658 | 517 | 321 | 307 | 471 | 395 | 354 | 890 | 1,339 | 1,136 | 1,087 |
| Other Liabilities | 846 | 823 | 820 | 1,006 | 799 | 790 | 983 | 1,152 | 1,250 | 1,199 | 1,431 | 1,439 |
| Total Liabilities | 2,187 | 2,069 | 1,886 | 1,929 | 1,608 | 1,483 | 1,711 | 2,105 | 2,713 | 2,907 | 2,936 | 2,971 |
| Fixed Assets | 1,176 | 1,270 | 1,134 | 935 | 898 | 703 | 691 | 702 | 783 | 1,217 | 1,264 | 1,247 |
| CWIP | 206 | 3 | 6 | 16 | 11 | 7 | 9 | 35 | 324 | 105 | 36 | 38 |
| Investments | 10 | 4 | 16 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 795 | 791 | 730 | 977 | 698 | 773 | 1,012 | 1,368 | 1,605 | 1,584 | 1,636 | 1,685 |
| Total Assets | 2,187 | 2,069 | 1,886 | 1,929 | 1,608 | 1,483 | 1,711 | 2,105 | 2,713 | 2,907 | 2,936 | 2,971 |
Below is a detailed analysis of the balance sheet data for Indo Rama Synthetics (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 261.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 261.00 Cr..
- For Reserves, as of Sep 2025, the value is 184.00 Cr.. The value appears strong and on an upward trend. It has increased from 107.00 Cr. (Mar 2025) to 184.00 Cr., marking an increase of 77.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,087.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 1,136.00 Cr. (Mar 2025) to 1,087.00 Cr., marking a decrease of 49.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,439.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,431.00 Cr. (Mar 2025) to 1,439.00 Cr., marking an increase of 8.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,971.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,936.00 Cr. (Mar 2025) to 2,971.00 Cr., marking an increase of 35.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,247.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,264.00 Cr. (Mar 2025) to 1,247.00 Cr., marking a decrease of 17.00 Cr..
- For CWIP, as of Sep 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 38.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,685.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,636.00 Cr. (Mar 2025) to 1,685.00 Cr., marking an increase of 49.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,971.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,936.00 Cr. (Mar 2025) to 2,971.00 Cr., marking an increase of 35.00 Cr..
However, the Borrowings (1,087.00 Cr.) are higher than the Reserves (184.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -672.00 | -631.00 | -395.00 | -260.00 | -327.00 | -493.00 | -302.00 | -50.00 | -846.00 | -38.00 | 178.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 16 | 16 | 29 | 20 | 16 | 19 | 17 | 14 | 16 | 14 |
| Inventory Days | 46 | 48 | 46 | 48 | 36 | 57 | 102 | 67 | 73 | 67 | 65 |
| Days Payable | 80 | 87 | 92 | 136 | 132 | 126 | 221 | 126 | 125 | 120 | 142 |
| Cash Conversion Cycle | -24 | -23 | -30 | -60 | -76 | -53 | -100 | -43 | -38 | -38 | -63 |
| Working Capital Days | -50 | -42 | -43 | -50 | -69 | -52 | -62 | -22 | -25 | -81 | -73 |
| ROCE % | -8% | 1% | -1% | -8% | 11% | 33% | 3% | -4% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
| Diluted EPS (Rs.) | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
| Cash EPS (Rs.) | 1.90 | -6.29 | 0.25 | 11.50 | 5.63 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.10 | 14.10 | 21.93 | 22.99 | 12.76 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.10 | 14.10 | 21.93 | 22.99 | 12.76 |
| Revenue From Operations / Share (Rs.) | 163.11 | 148.34 | 156.44 | 154.65 | 78.24 |
| PBDIT / Share (Rs.) | 7.92 | -1.25 | 2.54 | 11.97 | 4.39 |
| PBIT / Share (Rs.) | 6.08 | -2.75 | 1.34 | 10.77 | 3.10 |
| PBT / Share (Rs.) | 0.05 | -7.79 | -0.94 | 8.40 | 0.12 |
| Net Profit / Share (Rs.) | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
| NP After MI And SOA / Share (Rs.) | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
| PBDIT Margin (%) | 4.85 | -0.84 | 1.62 | 7.74 | 5.61 |
| PBIT Margin (%) | 3.72 | -1.85 | 0.85 | 6.96 | 3.96 |
| PBT Margin (%) | 0.03 | -5.25 | -0.60 | 5.43 | 0.16 |
| Net Profit Margin (%) | 0.03 | -5.25 | -0.60 | 6.66 | 5.54 |
| NP After MI And SOA Margin (%) | 0.03 | -5.25 | -0.60 | 6.66 | 5.54 |
| Return on Networth / Equity (%) | 0.38 | -55.26 | -4.28 | 44.82 | 34.02 |
| Return on Capital Employeed (%) | 20.27 | -8.97 | 2.91 | 33.63 | 13.26 |
| Return On Assets (%) | 0.04 | -6.99 | -0.90 | 12.77 | 6.62 |
| Long Term Debt / Equity (X) | 0.97 | 0.99 | 0.97 | 0.28 | 0.69 |
| Total Debt / Equity (X) | 3.06 | 3.58 | 1.51 | 0.53 | 0.91 |
| Asset Turnover Ratio (%) | 1.46 | 1.38 | 1.70 | 2.07 | 1.27 |
| Current Ratio (X) | 0.62 | 0.60 | 0.85 | 0.81 | 0.69 |
| Quick Ratio (X) | 0.34 | 0.32 | 0.43 | 0.39 | 0.32 |
| Inventory Turnover Ratio (X) | 7.19 | 4.62 | 5.12 | 6.16 | 4.49 |
| Interest Coverage Ratio (X) | 1.32 | -0.24 | 1.11 | 5.05 | 1.74 |
| Interest Coverage Ratio (Post Tax) (X) | 1.01 | -0.54 | 0.58 | 5.35 | 2.90 |
| Enterprise Value (Cr.) | 1984.69 | 2303.81 | 1824.56 | 2023.51 | 1310.44 |
| EV / Net Operating Revenue (X) | 0.46 | 0.59 | 0.44 | 0.50 | 0.64 |
| EV / EBITDA (X) | 9.60 | -70.43 | 27.56 | 6.47 | 11.42 |
| MarketCap / Net Operating Revenue (X) | 0.20 | 0.26 | 0.24 | 0.42 | 0.49 |
| Price / BV (X) | 2.41 | 2.76 | 1.78 | 2.86 | 3.05 |
| Price / Net Operating Revenue (X) | 0.20 | 0.26 | 0.24 | 0.42 | 0.49 |
| EarningsYield | 0.00 | -0.20 | -0.02 | 0.15 | 0.11 |
After reviewing the key financial ratios for Indo Rama Synthetics (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has increased from -6.29 (Mar 24) to 1.90, marking an increase of 8.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.10. There is no change compared to the previous period (Mar 24) which recorded 14.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.10. There is no change compared to the previous period (Mar 24) which recorded 14.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 163.11. It has increased from 148.34 (Mar 24) to 163.11, marking an increase of 14.77.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.92. This value is within the healthy range. It has increased from -1.25 (Mar 24) to 7.92, marking an increase of 9.17.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.08. This value is within the healthy range. It has increased from -2.75 (Mar 24) to 6.08, marking an increase of 8.83.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.05. This value is within the healthy range. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For PBDIT Margin (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has increased from -0.84 (Mar 24) to 4.85, marking an increase of 5.69.
- For PBIT Margin (%), as of Mar 25, the value is 3.72. This value is below the healthy minimum of 10. It has increased from -1.85 (Mar 24) to 3.72, marking an increase of 5.57.
- For PBT Margin (%), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 10. It has increased from -5.25 (Mar 24) to 0.03, marking an increase of 5.28.
- For Net Profit Margin (%), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -5.25 (Mar 24) to 0.03, marking an increase of 5.28.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 8. It has increased from -5.25 (Mar 24) to 0.03, marking an increase of 5.28.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 15. It has increased from -55.26 (Mar 24) to 0.38, marking an increase of 55.64.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.27. This value is within the healthy range. It has increased from -8.97 (Mar 24) to 20.27, marking an increase of 29.24.
- For Return On Assets (%), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -6.99 (Mar 24) to 0.04, marking an increase of 7.03.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.97. This value is within the healthy range. It has decreased from 0.99 (Mar 24) to 0.97, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.06. This value exceeds the healthy maximum of 1. It has decreased from 3.58 (Mar 24) to 3.06, marking a decrease of 0.52.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.46. It has increased from 1.38 (Mar 24) to 1.46, marking an increase of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1.5. It has increased from 0.60 (Mar 24) to 0.62, marking an increase of 0.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.34, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.19. This value is within the healthy range. It has increased from 4.62 (Mar 24) to 7.19, marking an increase of 2.57.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 3. It has increased from -0.24 (Mar 24) to 1.32, marking an increase of 1.56.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 3. It has increased from -0.54 (Mar 24) to 1.01, marking an increase of 1.55.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,984.69. It has decreased from 2,303.81 (Mar 24) to 1,984.69, marking a decrease of 319.12.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has decreased from 0.59 (Mar 24) to 0.46, marking a decrease of 0.13.
- For EV / EBITDA (X), as of Mar 25, the value is 9.60. This value is within the healthy range. It has increased from -70.43 (Mar 24) to 9.60, marking an increase of 80.03.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 24) to 0.20, marking a decrease of 0.06.
- For Price / BV (X), as of Mar 25, the value is 2.41. This value is within the healthy range. It has decreased from 2.76 (Mar 24) to 2.41, marking a decrease of 0.35.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 24) to 0.20, marking a decrease of 0.06.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 24) to 0.00, marking an increase of 0.20.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Indo Rama Synthetics (India) Ltd:
- Net Profit Margin: 0.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.27% (Industry Average ROCE: 4.2%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.38% (Industry Average ROE: 2.96%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.01
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.34
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 7.42 (Industry average Stock P/E: 38.21)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Spinning - Synthetic Blended | A-31, MIDC Industrial Area, Nagpur Maharashtra 441122 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Om Prakash Lohia | Chairman & Managing Director |
| Mr. Vishal Lohia | Whole Time Director |
| Mr. Sanjay Thapliyal | Whole Time Director |
| Mr. Dilip Kumar Agarwal | Non Exe.Non Ind.Director |
| Ms. Ranjana Agarwal | Ind. Non-Executive Woman Director |
| Mr. Dhanendra Kumar | Ind. Non-Executive Director |
| Mr. Dharmpal Agarwal | Ind. Non-Executive Director |
| Mr. Ravi Capoor | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Indo Rama Synthetics (India) Ltd?
Indo Rama Synthetics (India) Ltd's intrinsic value (as of 22 January 2026) is ₹0.60 which is 98.51% lower the current market price of ₹40.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,051 Cr. market cap, FY2025-2026 high/low of ₹75.0/29.1, reserves of ₹184 Cr, and liabilities of ₹2,971 Cr.
What is the Market Cap of Indo Rama Synthetics (India) Ltd?
The Market Cap of Indo Rama Synthetics (India) Ltd is 1,051 Cr..
What is the current Stock Price of Indo Rama Synthetics (India) Ltd as on 22 January 2026?
The current stock price of Indo Rama Synthetics (India) Ltd as on 22 January 2026 is ₹40.2.
What is the High / Low of Indo Rama Synthetics (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Indo Rama Synthetics (India) Ltd stocks is ₹75.0/29.1.
What is the Stock P/E of Indo Rama Synthetics (India) Ltd?
The Stock P/E of Indo Rama Synthetics (India) Ltd is 7.42.
What is the Book Value of Indo Rama Synthetics (India) Ltd?
The Book Value of Indo Rama Synthetics (India) Ltd is 17.1.
What is the Dividend Yield of Indo Rama Synthetics (India) Ltd?
The Dividend Yield of Indo Rama Synthetics (India) Ltd is 0.00 %.
What is the ROCE of Indo Rama Synthetics (India) Ltd?
The ROCE of Indo Rama Synthetics (India) Ltd is 9.94 %.
What is the ROE of Indo Rama Synthetics (India) Ltd?
The ROE of Indo Rama Synthetics (India) Ltd is 0.66 %.
What is the Face Value of Indo Rama Synthetics (India) Ltd?
The Face Value of Indo Rama Synthetics (India) Ltd is 10.0.